SEATTLE – Trinity College Dublin next month will host an intensive, three-day short course in high-content cellular imaging and analysis on its campus in Ireland, Anthony Davies, HCS coordinator at Trinity College’s high-content analysis facility, said at the Society for Biomolecular Sciences conference held here this week.
The course is intended to be platform-independent, and offers an alternative or supplement to Cellomics’ successful ‘HCS 101’ and ‘HCS 102’ short courses. However, Cellomics and other industry participants in the Trinity College course see it as an opportunity to expand the HCA market, Davies said.
The course, which is set to run Oct. 1-3, will feature hands-on high-content analysis exercises, and will cover areas such as algorithm development, experimental design, instrumentation options, image analysis, automation and liquid handling, database storage and management, and applications such as industrial drug screening and high-throughput siRNA screening.
“Generally these short courses are more conference based,” Davies told CBA News at the SBS conference. “We’re not using the conference format. This is a proper class with proper lectures, and all kinds of practical hands-on demonstrations where people will be directly involved with the instrumentation.”
The course is open to participants from academia and industry, and will feature presentations from HCS instrument, software, reagent, and automation vendors, as well as prominent academic and pharmaceutical scientists in the field.
The only other intensive HCS short course is the so-called “HCS Bootcamp,” which Fisher Bioscience unit Cellomics offers several times a year for current and prospective customers.
“Many of these organizations and our collaborators identified the need for a platform-independent, commercially independent course, but obviously much of the expertise lies within industry,” Davies said. “So we needed to set up something where we could get the maximum expertise and training for our people, without any of the corporate spin that’s attached to that. And this is what’s been done. We’ve gathered very skilled and knowledgeable people.”
Davies said that Cellomics has been supportive of his efforts. “They see this as something that will benefit the field in general,” he said. In general, “some of the companies involved have seen that there is a need for this and that it will only improve the market,” Davies added. “That’s where we’re really focused, to try and provide something that’s going to give people a taste and good grounding in this area.”
Cellomics scientists will present at the short course, as will scientists from GE Healthcare, BD Biosciences, Fisher BioImage, Deerac Fluids, Spotfire, and AstraZeneca.
Davies said that the course started as “almost a spin-off” of a Master’s program that Trinity College Dublin offers in molecular medicine, and “we have just set up an expanded module in this existing Master’s HCA course, which we’ll eventually push into a full Master’s program in high-content analysis.”
The course is €3,000 (about $3,800) for academic participants and €5,000 for industrial or commercial participants. Course fees include the educational program, accommodation, meals, and social events.
Additional information can be found here. Although GE Healthcare is hosting a web site for the course, Davies said that the course is not corporate sponsored.